Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
REXULTI
Overview
What is REXULTI?
Brexpiprazole, an atypical antipsychotic, is available as REXULTI (brexpiprazole) tablets. Brexpiprazole is 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1)-one. The empirical formula is CHNOS and its molecular weight is 433.57. The chemical structure is:
REXULTI tablets are for oral administration and are available in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg strengths. Inactive ingredients include lactose monohydrate, corn starch, microcrystalline cellulose, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, magnesium stearate, hypromellose, and talc. Colorants include titanium dioxide, iron oxide and ferrosferric oxide.
What does REXULTI look like?
What are the available doses of REXULTI?
Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg ()
What should I talk to my health care provider before I take REXULTI?
Pregnancy:
8.1
How should I use REXULTI?
REXULTI is indicated for:
The recommended starting dosage for REXULTI as adjunctive treatment is 0.5 mg or 1 mg once daily, taken orally with or without food
Titrate to 1 mg once daily, then up to the target dosage of 2 mg once daily. Dosage increases should occur at weekly intervals based on the patient's clinical response and tolerability. The maximum recommended daily dosage is 3 mg. Periodically reassess to determine the continued need and appropriate dosage for treatment.
What interacts with REXULTI?
Sorry No Records found
What are the warnings of REXULTI?
Sorry No Records found
What are the precautions of REXULTI?
Sorry No Records found
What are the side effects of REXULTI?
Sorry No records found
What should I look out for while using REXULTI?
REXULTI is contraindicated in patients with a known hypersensitivity to brexpiprazole or any of its components. Reactions have included rash, facial swelling, urticaria, and anaphylaxis.
Use with Other CNS Depressants
Use with Imipramine and Desipramine
Drugs that inhibit alprazolam metabolism via cytochrome P450 3A
Drugs demonstrated to be CYP3A inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam (caution is recommended during coadministration with alprazolam)
Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam)
in vitro
in vivo
in vitro
Drugs demonstrated to be inducers of CYP3A
What might happen if I take too much REXULTI?
There is limited clinical trial experience regarding human overdosage with REXULTI.
Consult a Certified Poison Control Center ( or ) for up-to-date guidance and advice regarding a REXULTI overdosage. Management of overdose should concentrate on supportive therapy, maintaining an adequate airway, oxygenation and ventilation, and management of symptoms. Close medical supervision and monitoring should continue until the patient recovers.
How should I store and handle REXULTI?
Store REXULTI tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) .Alprazolam tablets are available as follows: (White colored, oval shaped biconvex tablets one side debossed by ‘N’ on the left side and ‘A’ on the right side of score line and other side debossed with ‘0.25’)Bottles of 20 NDC 68788-6865-2Bottles of 30 NDC 68788-6865-3Bottles of 60 NDC 68788-6865-6Bottles of 90 NDC 68788-6865-9 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Alprazolam tablets are available as follows: (White colored, oval shaped biconvex tablets one side debossed by ‘N’ on the left side and ‘A’ on the right side of score line and other side debossed with ‘0.25’)Bottles of 20 NDC 68788-6865-2Bottles of 30 NDC 68788-6865-3Bottles of 60 NDC 68788-6865-6Bottles of 90 NDC 68788-6865-9 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Alprazolam tablets are available as follows: (White colored, oval shaped biconvex tablets one side debossed by ‘N’ on the left side and ‘A’ on the right side of score line and other side debossed with ‘0.25’)Bottles of 20 NDC 68788-6865-2Bottles of 30 NDC 68788-6865-3Bottles of 60 NDC 68788-6865-6Bottles of 90 NDC 68788-6865-9 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Alprazolam tablets are available as follows: (White colored, oval shaped biconvex tablets one side debossed by ‘N’ on the left side and ‘A’ on the right side of score line and other side debossed with ‘0.25’)Bottles of 20 NDC 68788-6865-2Bottles of 30 NDC 68788-6865-3Bottles of 60 NDC 68788-6865-6Bottles of 90 NDC 68788-6865-9 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Alprazolam tablets are available as follows: (White colored, oval shaped biconvex tablets one side debossed by ‘N’ on the left side and ‘A’ on the right side of score line and other side debossed with ‘0.25’)Bottles of 20 NDC 68788-6865-2Bottles of 30 NDC 68788-6865-3Bottles of 60 NDC 68788-6865-6Bottles of 90 NDC 68788-6865-9 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].
